Colgate-Palmolive Co has a consensus price target of $78.67, established from looking at the 70 latest analyst ratings. The last 3 analyst ratings were released from Goldman Sachs, Morgan Stanley, and UBS on March 1, 2024, January 29, 2024, and January 29, 2024. With an average price target of $93.67 between Goldman Sachs, Morgan Stanley, and UBS, there's an implied 4.13% upside for Colgate-Palmolive Co from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/01/2024 | CL | Buy Now | Colgate-Palmolive | $89.95 | 3.39% | Goldman Sachs | Jason English | → $93 | Reinstates | → Buy | Get Alert |
01/29/2024 | CL | Buy Now | Colgate-Palmolive | $89.95 | 3.39% | Morgan Stanley | Dara Mohsenian | $85 → $93 | Maintains | Overweight | Get Alert |
01/29/2024 | CL | Buy Now | Colgate-Palmolive | $89.95 | 5.61% | UBS | Peter Grom | $93 → $95 | Maintains | Buy | Get Alert |
01/29/2024 | CL | Buy Now | Colgate-Palmolive | $89.95 | -2.17% | Wells Fargo | Chris Carey | $80 → $88 | Maintains | Equal-Weight | Get Alert |
01/29/2024 | CL | Buy Now | Colgate-Palmolive | $89.95 | 1.17% | Raymond James | Olivia Tong | → $91 | Upgrade | Market Perform → Outperform | Get Alert |
01/18/2024 | CL | Buy Now | Colgate-Palmolive | $89.95 | 0.06% | JP Morgan | Andrea Teixeira | $88 → $90 | Maintains | Overweight | Get Alert |
01/16/2024 | CL | Buy Now | Colgate-Palmolive | $89.95 | -8.84% | Barclays | Lauren Lieberman | $75 → $82 | Maintains | Equal-Weight | Get Alert |
12/15/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | 0.06% | B of A Securities | Bryan Spillane | → $90 | Upgrade | Neutral → Buy | Get Alert |
11/29/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -2.17% | JP Morgan | Andrea Teixeira | $83 → $88 | Maintains | Overweight | Get Alert |
11/13/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -3.28% | Jefferies | Kaumil Gajrawala | → $87 | Initiates | → Buy | Get Alert |
10/30/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -11.06% | RBC Capital | Nik Modi | $79 → $80 | Maintains | Sector Perform | Get Alert |
10/30/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -5.5% | Morgan Stanley | Dara Mohsenian | $89 → $85 | Maintains | Overweight | Get Alert |
10/17/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -16.62% | B of A Securities | Bryan Spillane | $85 → $75 | Maintains | Neutral | Get Alert |
10/16/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -9.95% | Stifel | Mark Astrachan | $85 → $81 | Upgrade | Hold → Buy | Get Alert |
10/12/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -18.84% | Barclays | Lauren Lieberman | $81 → $73 | Maintains | Equal-Weight | Get Alert |
10/12/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -9.95% | JP Morgan | Andrea Teixeira | $85 → $81 | Maintains | Overweight | Get Alert |
10/11/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -5.5% | Citigroup | Filippo Falorni | $92 → $85 | Maintains | Buy | Get Alert |
09/22/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -6.61% | HSBC | Alejandro Zamacona | → $84 | Initiates | → Buy | Get Alert |
08/01/2023 | CL | Buy Now | Colgate-Palmolive | $89.95 | -9.95% | Barclays | Lauren Lieberman | $77 → $81 | Maintains | Equal-Weight | Get Alert |
The latest price target for Colgate-Palmolive (NYSE: CL) was reported by Goldman Sachs on March 1, 2024. The analyst firm set a price target for $93.00 expecting CL to rise to within 12 months (a possible 3.39% upside). 29 analyst firms have reported ratings in the last year.
The latest analyst rating for Colgate-Palmolive (NYSE: CL) was provided by Goldman Sachs, and Colgate-Palmolive their buy rating.
The last upgrade for Colgate-Palmolive Co happened on January 29, 2024 when Raymond James raised their price target to $91. Raymond James previously had a market perform for Colgate-Palmolive Co.
The last downgrade for Colgate-Palmolive Co happened on May 3, 2022 when Atlantic Equities changed their price target from $92 to $80 for Colgate-Palmolive Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Colgate-Palmolive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Colgate-Palmolive was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.
While ratings are subjective and will change, the latest Colgate-Palmolive (CL) rating was a with a price target of $0.00 to $93.00. The current price Colgate-Palmolive (CL) is trading at is $89.95, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.